COVID-19 Resource Center
As the pandemic enters it’s third year, the Quadax Resource Center is here to help keep you up to date on the latest COVID-19 topics, including payor and billing changes affecting reimbursement.
COVID-19 Payer Updates
Quadax is dedicated to keeping our clients up-to-date on the billing, reporting, and procedural information specific to each payer as it pertains to COVID-19.
Recent Blog Posts
2021 CAQH Report: Potential Savings Up 32% for Healthcare Transactions
Potential savings from automating common healthcare administrative transactions increased 32% due to higher costs for more complex manual transactions due to the demands of working through a national pandemic, finds the 2021 CAQH Index.
As COVID-19 forced people to work from home and practice social distancing, health plan and provider staff did not have access to office equipment and/or were closed temporarily, meaning staff relied more on the use of electronic transactions to conduct administrative transactions. Conversely, medical transaction volume was down 11% due to healthcare policies, regulations, resources and social behaviors.
COVID-19 Articles, Bulletins, Town Halls, Webinars
Date | Article | Source |
6/14/2022 | The FDA issued an emergency use authorization (EUA) for the Laboratory Corporation of America (Labcorp) VirSeq SARS-CoV-2 NGS Test on the PacBio Sequel II sequencing system. | |
6/8/2022 | COVID-19 test demand a boon for labs, a bane for costs, study finds | |
6/7/2022 | New Current Procedural Terminology (CPT®) codes have been created that streamline the reporting of immunizations for the novel coronavirus (SARS-CoV-2, also known as COVID-19). | |
6/7/2022 | FDA Roundup: Additional guidance to help prescribers evaluate potential drug interactions when using Paxlovid therapy for COVID-19 | |
6/3/2022 | HHS Extends American Rescue Plan Spending Deadline for States to Expand and Enhance Home- and Community-Based Services for People with Medicaid | |
5/26/2022 | New Administration Code for Pfizer Pediatric Vaccine Booster Dose. | |
5/25/2022 | Provider Relief Fund Reporting Requirements and Auditing | |
5/25/2022 | What Happens to COVID Tests After Public Health Emergency Ends? | |
5/20/2022 | Know Your Treatment Options for COVID-19 Consumer Update - Refreshed | |
5/17/2022 | The FDA issued an Emergency Use Authorization (EUA) for the Laboratory Corporation of America (Labcorp) Pixel by Labcorp COVID-19+Flu+RSV Test Home Collection Kit for use with the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test | |
5/17/2022 | Federal government offers more free COVID-19 tests | |
5/16/2022 | HHS to Discontinue Providing Viral Transport Media to States and Jurisdictions | |
5/16/2022 | Hospital Groups Ask HHS to Expand COVID-19 Public Health Emergency | |
5/10/2022 | U.S. will limit next-generation Covid vaccines to high-risk people this fall if Congress doesn’t approve more funding | |
5/6/2022 | Rising hospitalizations put CDC's COVID-19 prevention guidelines to the test | |
5/5/2022 | Federal funds for uninsured COVID patients dry up as hospital costs rise | |
5/5/2022 | Labor, Medications, and Supply Costs Plague Hospitals and Health Systems | |
5/4/2022 | How One Medicaid Program May Prevent Coverage Loss Post-COVID | |
5/5/2022 | FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals | |
5/2/2022 | Loss of Pandemic Aid Stresses Hospitals That Treat The Uninsured | |
4/27/2022 | COVID-19 Uninsured Relief Fund Joint Letter | |
4/26/2022 | FACT SHEET: Biden Administration Increases Access to COVID-19 Treatments and Boosts Patient and Provider Awareness | |
4/26/2022 | CDC estimates 58% of Americans have been infected with SARS-CoV-2 | |
4/26/2022 | White House expands access to COVID-19 antiviral pills | |
4/19/2022 | HHS Distributes $1.75B in Phase 4 COVID-19 Provider Relief Funds | |
4/14/2022 | COVID-19: New Codes for Moderna Vaccine Booster Doses | |
4/12/2022 | Renewal of Determination That A Public Health Emergency Exists | |
4/7/2022 | System Limitation Update for Centralized Flu Billers (CFB), Pneumococcal and Covid-19 Vaccinations | |
4/6/2022 | The Uninsured Program stopped accepting claims due to a lack of sufficient funds | |
4/6/2022 | Eligible Individuals Can Receive Second COVID-19 Booster Shot at No Cost | |
4/4/2022 | Telehealth Place of Service Code | |
4/4/2022 | Biden-Harris Administration Announces New Way for Medicare Beneficiaries to Get Free Over-the-Counter COVID-19 Tests | |
4/1/2022 | FDA Roundup - Revised guidance: Emergency Use Authorization for Vaccines to Prevent COVID-19 | |
3/31/2022 | Medicare Fee-for-Service Claims and the Sequestration Payment Adjustment Changes | |
3/31/2022 | COVID-19 guidance for your community | |
3/31/2022 | COVID pandemic’s end may bring turbulence for US health care | |
3/29/2022 | FDA Roundup: Manufacturing change for Moderna COVID-19 Vaccine | |
3/29/2022 | FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals | |
3/27/2022 | Post-Pandemic Strategies for Labs Include OIG Audit Prep and Repurposed Instruments | |
3/25/2022 | Free COVID-19 tests ending for uninsured Americans | |
3/23/2022 | AHA urges Congress to provide additional COVID-19 relief | |
3/22/2022 | COVID budget impasse halts aid to test and treat uninsured | |
3/22/2022 | Lab Advisory: Upcoming Schedule Changes for Clinical Laboratory COVID-19 Response Calls | |
3/22/2022 | HHS Distributing an Additional $413 Million in Provider Relief Fund Payments to Health Care Providers Impacted by the COVID-19 Pandemic | |
3/21/2022 | Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters | |
3/21/2022 | Lab Alert: FDA Recalls Specific Lot Numbers of Celltrion DiaTrust™ COVID-19 Ag Rapid Test | |
3/18/2022 | FDA Roundup: Additional COVID-19 Test FAQs. | |
3/17/2022 | Provider Relief Fund Reporting Period 2 | |
3/15/2022 | COVID-19 Claims Reimbursement - Uninsured Program Funds | |
3/11/2022 | FDA Roundup 3/11/22 | |
3/10/2022 | Lab Advisory 3/10/22. HHS Updates COVID-19 Laboratory Reporting Guidance. | |
3/10/2022 | AHA Asks CMS to Waive Medicare Advantage Prior Authorization During PHE | |
3/9/2022 | Congress set to add 151 days of telehealth coverage | |
3/8/2022 | Fact Sheet: Biden Administration Launches Nationwide Test-to-Treat Initiative Ensuring Rapid ‘On the Spot’ Access to Lifesaving COVID Treatments | |
3/8/2022 | Americans can now order four more free at-home Covid-19 tests | |
3/4/2022 | Biden extends FEMA COVID-19 funding through July 1 | |
3/2/2022 | Lab Alert: FDA Says Do Not Use These Unauthorized COVID-19 Tests | |
3/2/2022 | New ICD-10-CM/PCS Codes, Effective April 1, 2022 | |
3/1/2022 | FDA Roundup: COVID Testing Updates | |
2/25/2022 | FDA Roundup: COVID Testing Updates | |
2/24/2022 | HHS Distributing $560 Million in Provider Relief Fund Payments to Health Care Providers Affected by the COVID-19 Pandemic | |
2/21/2022 | COVID-19 CPT coding and guidance | |
2/18/2022 | FDA Roundup: COVID Vaccines & Testing Updates | |
2/16/2022 | COVID-19 Frequently Asked Questions (FAQs) on | |
2/11/2022 | Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant | |
2/8/2022 | On Feb. 4, the FDA warned people not to use the E25Bio COVID-19 Direct Antigen Rapid Test (DART) | |
2/8/2022 | Home Health Agency Providers May Be Reimbursed for COVID-19 Vaccine Administration | |
2/3/2022 | Biden-Harris Administration Will Cover Free Over-the-Counter COVID-19 Tests Through Medicare | |
2/1/2022 | AMA announces CPT update for pediatric COVID-19 vaccine candidate | |
1/28/2022 | Lab Update: CDC Updates LOINC In Vitro Diagnostic (LIVD) Test Code Mapping Tool for SARS-CoV-2 Tests | |
1/25/2022 | HHS Distributing $2 Billion More in Provider Relief Fund Payments to Health Care Providers Impacted by the COVID-19 Pandemic | |
1/24/2022 | Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant | |
1/21/2022 | New ICD-10 Code for Post-COVID Conditions, following the 2019 Novel Coronavirus (COVID_19). | |
1/20/2022 | Healthcare Common Procedure Coding System (HCPCS) Codes Subject to and Excluded from Clinical Laboratory Improvement Amendments (CLIA) Edits. | |
1/19/2022 | COVID-19 Vaccination Requirements for Health Care Providers and Suppliers - Requirement Infographic | |
1/14/2022 | Renewal of Determination That A Public Health Emergency Exists. | |
1/13/2022 | Lab Alert: Stop Using LuSys Laboratories COVID-19 Tests | |
1/10/2022 | Biden-Harris Administration Requires Insurance Companies and Group Health Plans to Cover the Cost of At-Home COVID-19 Tests, Increasing Access to Free Tests | |
1/6/2022 | COVID-19 Vaccine & Monoclonal Antibody Products: Changes for MA Plan Claims Started January 1 | |
1/4/2022 | CDC Warns of Supply Shortages as Testing Spikes in Wake of Omicron Variant | |
1/3/2022 | Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine | |
12/29/2021 | Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris | |
12/23/2021 | Coronavirus (COVID-19) Update: December 23, 2021 | |
12/23/2021 | HHS Announces Availability of Nearly $48 Million to Increase the Public Health Workforce in Rural and Tribal Communities | |
12/22/2021 | New Guidance to Boost Accessibility and Equity in COVID-19 Vaccine Programs | |
12/21/2021 | Coronavirus (COVID-19) Update: December 21, 2021 | |
12/17/2021 | Coronavirus (COVID-19) Update: December 17, 2021 | |
12/14/2021 | HHS Is Releasing $9 Billion in Provider Relief Fund Payments to Support Health Care Providers Affected by the COVID-19 Pandemic | |
12/10/2021 | The FDA updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to share the latest information | |
12/9/2021 | MLN Connects: Publications - Independent Diagnostic Testing Facility (IDTF)- Revised. | |
12/8/2021 | HHS Awards $82 Million in American Rescue Plan Funding to Expand Home Visiting Assistance for Families Affected by the COVID-19 Pandemic | |
12/7/2021 | COVID-19 Update: Announcing the follwing actions in ongoing response effort to the pandemic. | |
12/3/2021 | FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns | |
12/3/2021 | Lab Alert: CDC Update on the SARS-CoV-2 Omicron Variant | |
12/1/2021 | COVID-19 FAQs on | |
11/30/2021 | COVID-19 Update: The FDA is actively working to quickly address any potential impacts of the new omicron variant on the tools to fight the pandemic. | |
11/24/2021 | COVID-19: Pfizer & Modena Booster Shots for 18 Years and Older | |
11/23/2021 | COVID Update: Over-the-counter (OTC) COVID-19 antigen diagnostic tests | FDA |
11/22/2021 | Over The Counter (OTC) Home Testing and CLIA Applicability | |
11/18/2021 | Changes to Nursing Home Visitation COVID-19 (Revised) & COVID-19 Survey Activities | |
11/16/2021 | The FDA took several important actions intended to support ongoing nationwide COVID-19 testing efforts. | |
11/15/2021 | FDA Updates Test Policies to Help to Ensure Accuracy and Reliability of Tests and Increase Access to At-Home Tests | |
11/10/2021 | HHS Announces $143.5 Million to Expand Community-Based Efforts to Address Barriers to COVID-19 Vaccination | |
11/4/2021 | COVID-19 Vaccines for Children | |
11/4/2021 | Biden-Harris Administration Issues Emergency Regulation Requiring COVID-19 Vaccination for Health Care Workers | |
11/4/2021 | COVID-19 Vaccine Webinar for Rural Communities | |
10/27/2021 | HRSA COVID-19 Claims Reimbursement to Health Care Providers/ acilities for Testing and Treatment of the Uninsured | |
10/26/2021 | The FDA Issued an EUA for the Celltrion DiaTrust COVID-19 Ag Home Test, an OTC COVID-19 diagnostic antigen test. | |
10/21/2021 | Lab Alert: CDC Updates LOINC In Vitro Diagnostic (LIVD) Test Code Mapping Tool for SARS-CoV-2 Tests to Include SNOMED-CT Saliva Terms | |
10/21/2021 | CDC Expands Eligibility for COVID-19 Booster Shots | |
10/15/2021 | HHS renews COVID-19 emergency declaration for 90 days | |
10/5/2021 | COVID-19 Update | |
10/4/2021 | FDA Authorizes Additional OTC Home Test to Increase Access to Rapid Testing for Consumers | |
10/4/2021 | Lab Alert: Ellume Issues Voluntary Recall of Specific Lots of Ellume COVID-19 Home Tests | |
9/29/2021 | New COVID-19 Vaccine Codes: September Update | |
9/24/2021 | CMS Will Pay for COVID-19 Booster Shots, Eligible Consumers Can Receive at No Cost | |
9/22/2021 | Lab Advisory: CDC Updates SARS-CoV-2 Variant Classifications | |
9/22/2021 | FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations | |
9/10/2021 | COVID-19 Update | |
9/10/2021 | HHS Announces the Availability of $25.5 Billion in COVID-19 Provider Funding | |
9/3/2021 | AMA Announces Update to COVID-19 Vaccine CPT Codes | |
9/2/2021 | Lab Advisory: Shortage of COVID-19 Rapid Tests May Increase Demand for Laboratory Testing | |
9/2/2021 | Provider Enrollment Activities Resume in October | |
9/1/2021 | FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 Booster | |
8/24/2021 | CMS Expands Medicare Payments for At-Home COVID-19 Vaccinations | |
8/23/2021 | FDA Approves First COVID-19 Vaccine | |
8/18/2021 | Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots | |
8/9/2021 | UPDATE: Lab Advisory 8/9/21: SARS-CoV-2 Variant Classification Updates | |
8/6/2021 | Clinical Laboratory COVID-19 Response Call on Monday, August 23 at 3:00 PM ET | |
8/2/2021 | Lab Alert: Clarifications about the Retirement of the CDC 2019 Novel Coronavirus (2019-nCov) Real-Time RT-PCR Diagnostic Panel | |
8/2/2021 | Hospital Inpatient Prospective Payment System Final Rule Increases Payments to Treat COVID-19 and Improves Quality of Data Collection | |
7/30/2021 | Coronavirus (COVID-19) Update | |
7/21/2021 | Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing | |
7/20/2021 | Lab Advisory: SARS-CoV-2 Variant Classification Updates | |
7/18/2021 | Lab Alert: FDA Revokes EUA for Curative SARS-CoV-2 Assay | |
7/15/2021 | Lab Advisory: CDC Updates Pooling Guidance and Overview of Testing for SARS-CoV-2 Web Pages | |
7/13/2021 | Revised fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination. | |
7/8/2021 | COVID-19 Snapshot: Impact on the Medicare Population | |
7/8/2021 | COVID-19 Accelerated and Advance Payments: Updated FAQs. | |
7/6/2021 | Lab Advisory: SARS-CoV-2 Variants AY.1 and AY.2 Now Aggregated with Delta Variant B.1.617.2 | |
6/30/2021 | CDC Launches New COVID-19 Viral Testing Tool | |
6/29/2021 | Lab Update: SARS-CoV-2 Variant Classification Changes | |
6/17/2021 | CMS Infographic: Medicare Payment for COVID-19 Vaccination Administered in the Home | |
6/16/2021 | CDC Updates Guidance for Reporting SARS-CoV-2 Sequencing Results. | |
6/15/2021 | Coronavirus (COVID-19) Update | |
6/14/2021 | Lab Alert: Sodium Citrate Blood Specimen Collection Tubes in Short Supply | |
6/14/2021 | Lab Advisory: CDC Launches New COVID-19 Viral Testing Tool | |
6/10/2021 | CMS increase provider payment for in-home COVID-19 vaccinations | |
6/9/2021 | Biden Administration Continues Efforts to Increase Vaccinations by Bolstering Payments for At-Home COVID-19 Vaccinations for Medicare Beneficiaries | |
6/9/2021 | HHS Secretary Xavier Becerra to Insurers & Providers: COVID-19 Vaccines and Testing Must be Free for Patients | |
5/28/2021 | Lab Advisory: CDC Updates Testing Strategies for SARS-CoV-2 Web Page | |
5/25/2021 | Coronavirus (COVID-19) Update: May 25, 2021 | |
5/25/2021 | HHS to Dedicate $4.8 Billion from American Rescue Plan to COVID-19 Testing for the Uninsured | |
5/21/2021 | Coronavirus (COVID-19) Update: May 21, 2021 | |
5/20/2021 | Lab Advisory: CDC Updates NAATs and Self-Testing Web Pages | |
5/19/2021 | Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication | |
5/18/2021 | CDC Updates Interim Guidance for Antigen Testing for SARS-CoV-2 | |
5/5/2021 | SARS-CoV-2 Variant Classifications and Definitions | |
5/3/2021 | HHS Launches New Reimbursement Program for COVID-19 Vaccine Administration Fees not Covered by Insurance | |
4/26/2021 | Time to Say Goodbye to Some Insurers’ Waivers for Covid Treatment Fees | |
4/21/2021 | FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines | |
4/20/2021 | The FDA issued a pooling and serial testing amendment for many molecular diagnostic COVID-19 tests that had received an emergency use authorization (EUA) for testing individual samples. | |
4/16/2021 | Medicare FFS Claims: | |
4/15/2021 | Message from HHS-OIG Leadership on the COVID-19 Vaccination Program and Provider Compliance | |
4/6/2021 | The FDA issued an Emergency Use Authorization (EUA) to Symbiotica, Inc., for the COVID-19 Self-Collected Antibody Test System | |
4/2/2021 | HHS Secretary Xavier Becerra Announces Expansion of COVID-19 Vaccine Program to All Community Health Centers Across the Country | |
4/2/2021 | New web page posted: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular, antigen, and serology tests | |
4/1/2021 | Repayment of COVID-19 Accelerated and Advance Payments Began on March 30, 2021 | |
3/30/2021 | Updated Serology EUA COVID-19 Templates Available | |
3/30/2021 | New FDA web page - SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests - for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular tests | |
3/26/2021 | FDA issues emergency use authorization (EUA) to the Twist Bioscience Corporation for their SARS-CoV-2 NGS Assay | |
3/26/2021 | Lab Advisory: CDC Publishes New Web Page on Nucleic Acid Amplification Tests (NAATs) | |
3/22/2021 | Lab Update: CMS Posts FAQ for Reporting Sequencing Results for SARS-CoV-2 Variants | |
3/15/2021 | Medicare Payment Increase for COVID-19 Vaccine | |
3/13/2021 | Lab Alert: FDA Issues Letter about Potential False Results with Roche cobas SARS-CoV-2 & Influenza Test | |
3/9/2021 | Senate Passes $1.9 Trillion COVID-19 Bill; Several CAP-Backed Provisions Move Forward | |
3/9/2021 | FDA issued an Emergency Use Authorization (EUA) to Cue Health Inc. for its over-the-counter at-home diagnostic test for COVID-19. | |
3/9/2021 | Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies during the Public Health Emergency | |
3/5/2021 | COVID-19 Update: FDA Issues Authorization for First Molecular Non-Prescription, At-Home Test | |
3/4/2021 | COVID-19 Vaccine Administration: Insurance Coverage, MBI, & MSP | |
3/2/2021 | Lab Advisory: FDA Issues New Guidance for Evaluating Impact of Viral Mutations on COVID-19 Tests | |
3/2/2021 | COVID-19 Update: The agency issued an Emergency Use Authorization (EUA) to Quidel for its QuickVue At-Home COVID-19 Test for at-home use with a prescription | |
2/27/2021 | House Approves Large COVID-19 Relief Bill; Includes $7.5 Billion for Vaccine Distribution | |
2/26/2021 | Biden Administration Strengthens Requirements that Plans and Issuers Cover COVID-19 Diagnostic Testing Without Cost Sharing and Ensures Providers are Reimbursed for Administering COVID-19 Vaccines to Uninsured | |
2/26/2021 | ACLA Statement on President Biden’s Actions to Close Coverage Gaps for COVID-19 Testing | |
2/12/2021 | COVID-19 Update: The FDA revised its guidance, Investigational COVID-19 Convalescent Plasma and associated web page, to reflect the reissued Emergency Use Authorization for COVID-19 convalescent plasma | |
2/11/2021 | COVID-19: Revised Clinician Codes Accepted with CS Modifier | |
2/3/2021 | COVID-19 Claims Reimbursement Program Update for the Uninsured | |
2/2/2021 | Lab Advisory: CDC Publishes New Web Pages on Genomic Surveillance for SARS-CoV-2 Variants | |
1/29/2021 | COVID-19 Update: The FDA has added content to the Q&A appendix in “Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency" | |
1/28/2021 | HHS Announces Marketplace Special Enrollment Period for COVID-19 Public Health Emergency | |
1/21/2021 | ACLA Statement on President Biden's Actions to Combat COVID-19 | |
1/19/2021 | Find your COVID-19 Vaccine CPT® Codes | |
1/8/2021 | FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff | |
1/8/2021 | Coronavirus (COVID-19) Update: January 8, 2021 | |
1/4/2021 | New ICD-10-CM code for the | |
12/22/2020 | Coronavirus (COVID-19) Update: December 22, 2020 | |
12/19/2020 | CMS Updates FAQs for CLIA Guidance during the COVID-19 Public Health Emergency | |
12/15/2020 | FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine | |
12/15/2020 | FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19 | |
12/11/2020 | COVID-19 and in vitro diagnostics: New market forces at play | |
12/10/2020 | CMS offers guidance in billing Medicare for COVID-19 antibody treatment | |
12/10/2020 | FAQs–Application of OIG's Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency | |
12/7/2020 | Lab Advisory: CMS Revises Enforcement Discretion for SARS-CoV-2 Point-of-Care Tests | |
12/5/2020 | Lab Update: CDC Updates SARS-CoV-2 Antigen Testing Guidance | |
12/3/2020 | Lab Update: CDC Offers New COVID-19 Specimen Collection Infographics | |
12/4/2020 | 13 insurers extending COVID-19 cost-sharing waivers into 2021 | |
12/3/2020 | COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing | |
12/1/2020 | Job Aids for Laboratory Professionals | |
12/1/2020 | Clinical Laboratory COVID-19 Response Calls | |
11/24/2020 | Guidance for SARS-CoV-2 Point-of-Care Testing | |
11/24/2020 | Pathologists Advocate for Higher COVID-19 Payments During AMA Meeting | |
11/24/2020 | A Closer Look at COVID-19 Diagnostic Testing | |
11/23/2020 | 2020 Clinical Lab & Pathology Resources | |
11/19/2020 | HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19 | |
11/18/2020 | Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation | |
11/18/2020 | The FDA issued an EUA for the first COVID-19 diagnostic test for self-testing at home that provides rapid results | |
11/18/2020 | The FDA published a new "FDA Insight" podcast titled: "Personal Protective Equipment and COVID-19" | |
11/17/2020 | CAP Members Call on Congress to Stop Medicare Cuts | |
11/17/2020 | CAP Asks CMS to Reduce COVID-19 Laboratory Reporting Burdens, Increase Testing Resources | |
11/11/2020 | CMS Details Medicare Payment for New COVID-19 Antibody Drug | |
11/10/2020 | AMA Announces Vaccine-Specific CPT Codes for COVID-19 Immunizations | |
11/9/2020 | The FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients | |
11/2/2020 | Clinical Laboratories Need Creative Staffing Strategies to Keep and Attract Hard-to-Find Medical Technologists, as Demand for COVID-19 Testing Increases |
